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An antiserum (13CB) was generated against a synthetic peptidc, HDNLKQLMLQ. which is predicted to represent he C-terminal decapeptidc of 
the a subunit of the novel G-protein, G13. Competitive ELTSA indicated that the antiserum reacted with this peptide but that it showed minimal 
ability to recognize pcptides which represent he equivalent regions of the pertussis toxin-insensitive G-proteins, Gq + GI I. GI2, Gl5 + Gl6. GLl 
(also called Gl4) as Gz, and well as other G-proteins, Immunoblots of human platclct membranes with antiserum l3CB identifieda single43-kDa 
polypeptide. and while this immunoreactivity was abolished by the presence of the cognate pcptide it was not modified by the presence of pcptides 
corresponding to the equivalent region of other G-proteins. Immunorcactivity corresponding to G13a was detected in a range of cell types with 
human platelets having the highest levels of this polypcptide. 
Guanine nucleotide binding protein: Signal transduction 
1. INTRODUCTION 
The family of heterotrimeric guanine nucleotide bind- 
ing proteins (G-proteins) consists of a large number of 
individual members in which the molecular nature of 
the z subunit defines the identity of the G-protein [l]. 
Recent application of polymerasc hain reaction (PCR) 
technology has considerably expanded the number of 
G-protein a subunits which are known to be expressed 
[2]. In a number of cases the G-protein a subunit is, to 
date, known only from the isolation of a corresponding 
cDNA. One G- protein a subunit which falls into this 
class has been named G 1312 [3]. This G-protein is some- 
what distantly related at the primary sequence l vels to 
other identified G-proteins, and along with another G- 
protein (G12) of unidentified function has been 
proposed to define a separate class of G-proteins from 
those which had been identified previously [3]. We have 
taken advantage of the known cDNA sequence to gen- 
erate a specific antipeptide antiserum (13CB) against 
the a subunit of this G-protein. In this report we show 
the specificity of this antiserum for G13a and demon- 
strate, as predicted from the distribution of relevant 
mRNA [3], the widespread occurence of this poly- 
peptide. 
HDNLKQLMLQ-COOH, and keyhole limpet haemocyanin (KLH; 
Calbiochcm). An additional cysteine, to assist coupling of the peptide 
IO the protein, was placed at the N-terminal end of the peptidc. which 
is equivalent o the C-terminal decapcptide predicted for Gl3a. This 
pcptide was the kind gift of Dr. S.J. Arkinstall, Glaxo Institute for 
Molecular Biology, Geneva, Switzerland. Coupling of the peptidc and 
protein was achieved subsequent o the activation of KLH by treat- 
ment with n-malcimidobenzoylsulpho-succinimide ster [4] (Pierce 
and Warringer, Chester, UK). Antiserum CQ2, which identities the 
C-terminal decapeptidc of Gqa and Gl I a [4], SG I, which identifies 
the C-terminal decapeptidc of G,la and Gi2a [5], and CSI, which 
identilies the C-terminal decapeptide ofsplicc variants ofG,a [6J, have 
previously been described. 
Synthetic peptides corresponding to the C-terminal decapcptides of 
theasubunitsofGq/GII,G12,G,I (G14).G16,Gz.GiI/G,2,Gi3and 
G,l (Table I) which were used to assess potential interactions of 
antiserum l3CB with these other G-proteins were obtained either 
commercially from Biomac (Glasgow, Scotland) or as gifts from Dr. 
C.G. Unson, Department of Biochemistry, Rockerfeller University, 
New York, USA or Dr. S.J. Arkinstall. Glaxo Institute for Molecular 
Biology, Geneva, Switzerland. 
Table I 
The C-terminal decapeptides of the a subunits of a range ofG-proteins 
2. MATERlALS AND METHODS 
2. I. Antisera 
Cl3 
Gq/Gl I 
Gl2 
Gz 
G,_I(Gl4) 
GI6 
G,l/Gi2 
G,3 
HDNLKQLMLQ-COOH 
QLNLKEYNLV-COOH 
QENLKDIMLQ-COOH 
QNNLKYIGLC-COOH 
QLNLREFNLV-COOH 
ARYLDEINLL-COOH 
KNNLKDCGLF-COOH 
KNNLKECGLY-COOH 
Antiserum l3CB was generated in a New Zealand White rabbit 
which was immunized with a conjugate of a synthetic peptidc, 
Correspondcncc address: G. Milligan, Department of Biochemistry, 
University of Glasgow, Glasgow G12 SQQ, Scotland, UK. Fax: (44) 
(41) 330 4620. 
G” ANNLRGCGLY-COOH 
The above pcptidcs with, in the cases of GqlGl I, Gl2, G13 and Gl6, 
an additional N-terminal cysteine were used in competitive ELlSAs 
with antiserum 13CB (see Fig. 1 for results). Analysis of the full-length 
predicted amino acid sequences of the various G-proteins identitied 
no other Nptides in the primary amino acid sequences likely to cross- 
react with antiserum l3CB. 
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Immunoblouing was pcrfornied as in [S] using a horseradish per- 
oxidasc (HRP)-linked donkey anti-rabbit IgG fraction (Scottish An- 
tibody Production Unit. Carlukc. Scotland) as the secondary anti- 
serum. Visualization of the immunologically detected polypeplidc was 
achieved using o-dianisidine (Sigma) as subsrnlc for HRP. 
2.3. ELISA 
The reactivity of antiserum 13Cl3 againn 100 ng of the various 
synthclic pcptides was assessed by usingo-phcnylencdiamide dihydro- 
chloride as subslratc for HRP-linked secondary antibody. Colour 
production was measured at 492 nm on a Therick Mukiscan. 
Neuroblastoma x glioma hybrid NGIOB-15, glioma C6 BUI. rat I 
fibroblast and human monocyric U937 cells were grown in tissue 
cuhure as described previously [7.8]. In some cases cells were treated 
with either pertussis toxin (25 ng/ml, 16 h) or cholera toxin (I j@ml. 
I6 h) prior to harvest of ihc cells. Mcmbrancs from these cells and 
from rat cerebral cortex and human platelets were prcpurcd as in 191. 
3. RESULTS AND DISCUSSlON 
Competitive ELISA of the interaction of antiserum 
13CB with the peptide used for its generation (100 ng) 
indicated that half-maximal reactivity was observed at 
a 1:2,000 dilution of the crude antiserum (Fig. 1). No 
substantive cross-reactivity of this antiserum was noted 
with synthetic pcptides which represent the equivalent 
C-terminal regions of the tl subunits of the G-proteins, 
Gz, Gq -t GI 1, G12, Gl4, G15 -I- G16. Gil + Gi2, Gi3 
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Fig. I. ELISA reactivity of antiserum l3CD against peptides which 
correspond to the C-terminal decapcptidcs of a range of G-proteins. 
ELLSA asays were performed using 100 ng of pcptidcs corresponding 
to the C-terminal decapeptides of 0 I3 (a). G I2 (m). G I IlGq (A), Gz 
(*), Gil i-G,2 (II), C&3 (0) and G-1 (a). Further experiments with 
peptides equivalent to the C-terminal decapeptides of G,l (Gl4) and 
G I5 + GIG revealed no cross-reactivity between these peptides and 
antiserum l3CB. 
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Fig. 2. Immunological delcction of a 43bkDa polypepiide by antiserum 
13CB is prevented by the G 130 C-terminal decapcptide but not by the 
equivalent peptides of other pcrtussis toxin-insensitive G-proteins. 
Membranes (150 rug) Of human platclels wcrc scparalcd by SDS- 
PAGE (10% acrylamidc) and immunoblotted (lane I) with antiserum 
I3CB (I:200 dilution) or with this dilution of antiserum l3Cl3 in the 
prcscnce of I &ml of the C-terminal decapcptides corresponding to 
(lane 2) Glfrr, (lane 3) Gl2a. (lane 4) GI la + Gqa or (lane 5) G7z 
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and G,,l (Fig. 1 and results not shown). Such informa- 
tion indicates the likely specificity of antiserum 13CB 
for G13a. 
Immunoblotting of membranes of human platelets 
with antiserum 13CB identified a single polypeptide of 
43 kDa (Fig. 2). Pre-incubation ofantiserum 13CB with 
1 ,ug/ml of the peptide used to generate the antiserum 
abolished immunological detection of the 43-kDa poly- 
peptide. In contrast, pre-incubation of antiserum 13CB 
with the equivalent decapeptides (1pg/ml) of Gz. Gq/ 
G 11 and G 12, failed to reduce the immunological detec- 
tion of the 43-kDa polypeptide although these 4 other 
G-proteins, like G13, are predicted to be resistant o 
ADP-ribosylation catalysed by pertussis toxin, and 
share some 50-70% overall amino acid identity with 
G13a [2.3]. The polypeptide identified by antiserum 
13CB was not a substrate for pertussis toxin-catalysed 
ADP-ribosylation. We have previously noted that Gi2 
(and other pertussis toxin-sensitive G-proteins) migrate 
more slowly through SDS-PAGE following pertussis 
toxin-catalysed ADP-ribosylation (see [4] for example). 
Immunoblotting of membranes of untreated and 
pertussis toxin-treated C6 glioma cells with antiserum 
l3CB showed no difference in mobility of the identified 
43.kDa polypcptide in the 2 samples. Parallel immu- 
noblots of these membranes with antiserum SG 1, which 
in these cells identifies only G12a, demonstrated the 
anticipated reduced mobility of the 40-kDa polypeptide 
in membranes from the toxin-treated cells (data not 
shown). 
Cholera toxin treatment of cells has been shown to 
cause a considerable reduction in cellular levels of Gp 
(see [4] for example). Immunoblotting of membranes of
untreated and cholera toxin-pretreated C6glioma cells 
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with antiserum CSl, which identifies forms of G,a [B], 
confirmed these observations, but parallel immunoblots 
of these membranes with antiserum 13CB indicated that 
no alteration in membrane l vel of G13ar was produced 
by cholera toxin treatment (data not shown). 
As PCR RNA analysis has suggested that brain has 
only very low levels of G13a transcripts relative to other 
tissues [3], we immunoblotted rat brain cortical mem- 
branes with antiserum 13CB in concert with membranes 
from human platelets (Fig. 3b). As anticipated, immu- 
noreactivity in the rat brain membranes was below de- 
tectable levels. In a parallel experiment rat brain cortical 
membranes and human platelets were immunoblotted 
with antiserum CQ2 [4] to detect he presence of Gql 
G I 1 (Fig. 3a). CQ2 identified a single polypeptide of 42 
kDa in both brain and platelet membranes although 
immunoreactivity to this antiserum was markedly 
greater in platelet membranes than in brain membranes. 
Immunologically detected G l3a was expressed 
widely. We were able to detect a single polypeptide 
which co-migrated with the polypeptide xpressed in 
human platelets in each of neuroblastoma x glioma 
hybrid, NGlOS-15, rat glioma C6 cells, human mono- 
cytic U937 and human kidney EMBK cells (Fig. 4). On 
a per protein basis, of these cell lines glioma C6 cell 
membranes expressed the highest levels of G13a (Fig. 
4). The widespread istribution of the G13a polypep- 
tide was to be expected given the widespread etection 
of mRNA encoding this polypeptide. The function of 
this protein is currently unknown but it must presum- 
ably act to transmit information which is not disrupted 
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Fig. 3. Immunological detection of G13a in platelet but not brain 
membranes. Membranes (2Opg, Fig. 3a; 150~6, Fig. 3b) from human 
platelets (lanes I) and rat brain (lanes 2) were resolved as described 
in the legend to Fig. 2 and immunoblotted with either antiserum CQ? 
(Fig. 3a) or antiserum l3CB (Fig. 3b). Immunoreactivity correspond. 
ing to G13a was detected in platelet but not brain whilst immu- 
noreactivity corresponding toGqa/Gl la was detected inboth hsues. 
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Fig. 4. Widespread immunological detection of Gl3rr. Membranes 
(200 yg) from (I) human platelets, (2) ncuroblastomu x glioma 
NG108-I 5 hybrid cells, (3) rat glioma C6BU I cells. (4) Cl-IO cells, and 
(5) EMBK cells were resolved as in the legend to Fig. 2 and immu- 
noblottcd with antiserum I3CB (I:200 dilution) and the signal corrc- 
sponding to Gl3a quantitated by densitomctric scanning. Data are 
presented for the level of G I3a relative to that of platelets which have 
the highest level of this polypcptidc that WC have yet detected. 
by pertussis toxin treatment of cells. Antisera directed 
against the C-terminal regions of a variety of other 
G-proteins have been invaluable in defining interactions 
between these G-proteins and particular classes of re- 
ceptors [g-14]. It is hoped that the antibodies described 
in this report may similarly prove useful in defining the 
function of Gl3. 
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